BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25297505)

  • 1. CABG versus PCI in the treatment of diabetic patients affected by coronary artery disease.
    Nicolini F; Agostinelli A; Vezzani A; Benassi F; Gherli T
    Int Heart J; 2014; 55(6):469-73. PubMed ID: 25297505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery bypass graft surgery remains the standard of care for patients with diabetes.
    Moss E; Alam M; Ballantyne CM; Puskas JD
    Semin Thorac Cardiovasc Surg; 2013; 25(2):97-9. PubMed ID: 24216525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of acute coronary syndromes in patients with diabetes: implications of the FREEDOM trial.
    Burgess SN; Mussap CJ; French JK
    Clin Ther; 2013 Aug; 35(8):1069-75. PubMed ID: 23973040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PCI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease.
    Nyström T; Sartipy U; Franzén S; Eliasson B; Gudbjörnsdottir S; Miftaraj M; Lagerqvist B; Svensson AM; Holzmann MJ
    J Am Coll Cardiol; 2017 Sep; 70(12):1441-1451. PubMed ID: 28851544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial.
    Ben-Gal Y; Mohr R; Feit F; Ohman EM; Kirtane A; Xu K; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2015 Jun; 8(6):. PubMed ID: 26019142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes and multivessel disease: coronary artery bypass grafting remains king.
    Godoy LC; Rao V; Farkouh ME
    Curr Opin Cardiol; 2018 Sep; 33(5):551-557. PubMed ID: 29994804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.
    Bansilal S; Farkouh ME; Hueb W; Ogdie M; Dangas G; Lansky AJ; Cohen DJ; Magnuson EA; Ramanathan K; Tanguay JF; Muratov V; Sleeper LA; Domanski M; Bertrand ME; Fuster V
    Am Heart J; 2012 Oct; 164(4):591-9. PubMed ID: 23067919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Revascularization versus Percutaneous Coronary Intervention and Optimal Medical Therapy in Diabetic Patients with Multi-Vessel Coronary Artery Disease.
    Giustino G; Dangas GD
    Prog Cardiovasc Dis; 2015; 58(3):306-15. PubMed ID: 26255239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease.
    Gao F; Zhou YJ; Shen H; Wang ZJ; Yang SW; Liu XL
    Acta Diabetol; 2013 Oct; 50(5):765-73. PubMed ID: 22907763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies.
    Huang F; Lai W; Chan C; Peng H; Zhang F; Zhou Y; Teng S; Huang Z
    Cardiol J; 2015; 22(2):123-34. PubMed ID: 24846507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
    Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
    JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery.
    Razzouk L; Feit F; Farkouh ME
    Curr Cardiol Rep; 2017 May; 19(5):37. PubMed ID: 28374179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in the treatment of diabetic patients with multi-vessel coronary disease: a meta-analysis.
    Zhang F; Yang Y; Hu D; Lei H; Wang Y
    Diabetes Res Clin Pract; 2012 Aug; 97(2):178-84. PubMed ID: 22513345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial revascularization strategies in diabetic patients with multi-vessel disease: CABG vs DES-based PCI.
    Kassimis G; Patel N; Banning AP
    Curr Pharm Des; 2014; 20(28):4589-96. PubMed ID: 24568733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FREEDOM trial: in appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI.
    Aggarwal B; Goel SS; Sabik JF; Shishehbor MH
    Cleve Clin J Med; 2013 Aug; 80(8):515-23. PubMed ID: 23908108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease.
    Godoy LC; Ko DT; Rao V; Farkouh ME
    Prog Cardiovasc Dis; 2019; 62(4):358-363. PubMed ID: 31377224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.